Dr. Ken Staley was appointed in April 2018 to lead the President’s Malaria Initiative (PMI), the largest effort in history to control malaria in Africa and the Greater Mekong region in Asia. PMI is a collaborative U.S. Government effort led by the U.S. Agency for International Development (USAID) in conjunction with the Department of Health and Human Services (Centers for Disease Control and Prevention), the Department of State, the White House, and others. As coordinator, Dr. Staley reports to the USAID administrator and has primary responsibility for the oversight and coordination of all resources and international activities of the U.S. Government relating to efforts to combat malaria.
Prior to his appointment, Dr. Staley was a consultant at McKinsey and Company, where he assisted with large public health crisis responses to Ebola and Middle Eastern Respiratory Syndrome and also served clients in the pharmaceutical and medical device industries on strategic and operational topics. Prior to joining McKinsey, Dr. Staley was an executive at Medtronic, where he led several new Medtronic ventures aimed at expanding access to medical technology in emerging economies.
During the George W. Bush administration, Dr. Staley served as the Deputy Assistant Secretary for Counterproliferation (Acting) in the Department of State’s Bureau of International Security and Nonproliferation. His portfolio included preventing trafficking of weapons of mass destruction, their delivery systems, and related materials to and from states and non-state actors of proliferation concern, chemical and biological weapons multilateral arms control and non-proliferation, and responsible use of chemical and biological sciences.
Prior to his work at the Department of State, he served as Director for Biodefense Policy at the White House Homeland Security Council Biodefense Directorate, where he coordinated implementation of the National Strategy for Pandemic Influenza and development of policies related to biodefense preparedness and response activities for defense against intentional and naturally occurring biological threats.
Dr. Staley received his M.D. from the University of Iowa’s Carver College of Medicine, from which he also received a distinguished alumni award for early career achievement. He also holds a Master of Public Administration from Harvard Kennedy School and an A.B. in Biology from Washington University in Saint Louis.
Abstracts this author is presenting: